Serum Procalcitonin as a Diagnostic Marker for Systemic Inflammatory Response Syndrome in Intensive Care Unit Patients

Author:

Ramapriya Rama Mishra,Prakash Pallavi

Abstract

Introduction: Early assessment of Systemic Inflammatory Response Syndrome (SIRS) through various biomarkers like Procalcitonin (PCT), C-reactive Protein (CRP), Interleukin-1 (IL-1) etc., is crucial to manage the outcome of patients. Levels of PCT concerning its likelihood to distinguish patients with SIRS and non-SIRS and the possibility to predict mortality in patients with sepsis has been variable. Aim: To investigate the role of PCT in early diagnosis of sepsis in patients admitted to Intensive Care Unit (ICU). Materials and Methods: In this prospective observational study, 136 patients hospitalised in ICU at Vydehi Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India, between July 2019 to June 2020 were evaluated and PCT was analysed using Finecare™ PCT rapid test. Receiver Operating Characteristic (ROC) curve analysis and multiple logistic regression was carried out to detect the association of predictive PCT value with its outcomes. Results: PCT showed the best predictive value in the diagnosis of SIRS at 1.68 ng/mL (Area Under Curve (AUC)-0.87; p<0.05) having Positive Predictive Value (PPV) and Negative Predictive Value (NPV) of 90.43% and 73.81%, respectively. Multiple logistic regression model adjusted for age, weight, and duration of stay to predict the outcome of SIRS, positive blood culture and fatality case rate derived a significant association of PCT with Odds Ratio (OR) being 1.23 (1.11-2.31), 1.06 (1.01-1.98) and 1.76 (1.08-2.14), respectively. Conclusion: Early identification and treatment for sepsis significantly affects mortality. It appears that consecutive measurements of biomarkers could be valuable, but further prospective studies are important to characterise the role of PCT as a prognostic marker in sepsis and severe sepsis.

Publisher

JCDR Research and Publications

Subject

Clinical Biochemistry,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3